Last reviewed: May 16, 2026
Last updated: May 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Medvi pricing encompasses telehealth consultation fees, prescription costs, and ongoing program expenses. Understanding total treatment cost requires evaluating both provider fees and medication pricing, which vary based on formulation and dosing protocols across different GLP-1 options.
When evaluating GLP-1 treatment affordability, patients benefit from understanding how different delivery models—telehealth platforms, compounding pharmacies, and branded medications—structure their costs. This comparison supports informed conversations with healthcare providers about personalized, affordable wellness options.
Telehealth Platform Costs vs. Medication Expenses
Most telehealth GLP-1 providers separate consultation and prescription management fees from actual medication costs. Medvi and similar platforms typically charge for initial assessments and ongoing provider oversight, then separately bill for pharmaceuticals through their pharmacy partners.
Understanding this fee separation helps patients budget for both provider services and drug expenses. Some platforms offer subscription models bundling both components, while others charge à la carte, making total cost calculation essential before enrollment.
Compounded vs. Branded GLP-1 Pricing Framework
Compounded semaglutide and tirzepatide from licensed 503A pharmacies operate under different pricing and regulation models than branded medications like Ozempic, Wegovy, Zepbound, and Mounjaro. This comparison framework helps clarify cost drivers and supply considerations across different treatment pathways.
| Medication Type |
Typical Price Range |
Provider Model |
Pharmacy Regulation |
| Compounded Semaglutide |
$149/mo |
Direct-to-patient + telehealth |
Licensed 503A compounding |
| Compounded Tirzepatide |
$249/mo |
Direct-to-patient + telehealth |
Licensed 503A compounding |
| Branded Ozempic/Wegovy |
$900–$1,300/month |
Telehealth + insurance/GoodRx |
FDA-approved manufacturing |
| Branded Mounjaro/Zepbound |
$950–$1,400/month |
Telehealth + insurance/GoodRx |
FDA-approved manufacturing |
What Affects Total Treatment Cost
Multiple variables influence final GLP-1 treatment expenses: initial dosing protocol, titration schedule, frequency of provider visits, pharmacy partnership, insurance status, and whether genetic or biomarker testing informs medication selection. Patients should request itemized quotes from any provider.
Compounding pharmacies, including those partnered with PlexusDx, may offer fixed-cost options for full titration protocols or microdose approaches, potentially reducing unpredictable monthly variability. Telehealth platforms often bundle oversight fees differently than direct-pharmacy models.
Insurance Coverage and Cost-Sharing Considerations
Insurance coverage for compounded GLP-1 medications remains limited compared to branded options, as most plans require medical necessity documentation and may not recognize compounded formulations. Patients should verify their policy before enrollment to understand out-of-pocket obligations.
Many telehealth platforms offer cash-pay pricing without insurance involvement, which can simplify budgeting but removes potential insurer contribution. Understanding whether your insurance covers GLP-1 therapy—and at what cost-share tier—is essential before comparing platform pricing.
How PlexusDx Supports a More Personalized Approach
PlexusDx compounded medications from licensed 503A pharmacies offer transparent pricing ($129-$369/mo depending on formulation and protocol) without additional platform markups. When evaluating affordability, patients should understand that PlexusDx pricing reflects pharmaceutical manufacturing costs plus provider coordination, not telehealth subscription fees layered on medication costs.
The Precision Peptide Genetic Test may help provide context about how your genetic pathways (variants in GIPR, GLP1R, FTO, and MC4R genes) relate to peptide medications. While this test cannot predict exact medication response, understanding predispositions in these pathways can support conversations with providers about whether lower-cost compounded protocols or specific dosing strategies align with your genetic profile.
Cost-informed treatment selection should include discussion with a qualified healthcare provider about whether compounded peptides, branded medications, microdose approaches, or combination protocols align with both your budget and clinical needs. Genetic insights from the Precision Peptide test can enhance this conversation by contextualizing how your biology may influence treatment planning.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does PlexusDx pricing include telehealth visit fees or just medication cost?
PlexusDx compounded medication pricing ($249/mo) reflects pharmaceutical costs from licensed 503A pharmacies. Telehealth provider fees may apply separately depending on your care model. Confirm total cost structure with your provider before enrollment.
How much does a compounded GLP-1 full titration protocol cost with PlexusDx?
Compounded semaglutide titration ranges $149/mo; tirzepatide $249/mo. Microdose GLP-1 protocols start at $129/month. Final cost depends on starting dose, titration timeline, and pharmacy partner. Request itemized quotes for clarity.
Will my insurance cover PlexusDx compounded semaglutide or tirzepatide?
Compounded GLP-1 medications have limited insurance coverage compared to branded options. Most plans require medical necessity documentation. Contact your insurer before enrolling to understand whether compounded formulations are covered under your policy.
What safety considerations should I understand before starting any GLP-1 medication?
GLP-1 medications may cause nausea, injection site reactions, and rare pancreatitis. Patients with personal or family history of medullary thyroid cancer should avoid GLP-1 drugs. Work with a qualified provider to assess medical history, medications, and contraindications before starting treatment.
Can the Precision Peptide Genetic Test help me choose a less expensive GLP-1 option?
The Precision Peptide Genetic Test reveals predispositions in GIPR, GLP1R, FTO, and MC4R pathways, which may provide context for provider conversations about personalized dosing or formulation strategies. It cannot guarantee medication response or cost savings, but may support more targeted treatment planning with your provider.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Calibrate vs Noom: Clinical Evidence and Personalization Factors
Orderly Meds Pricing: Understanding Compounded GLP-1 Subscription Models